Blogs
Healthcare and Medtech Research Reports
Jul 07, 2023
With the anticipated launch of emerging therapies, the liver cirrhosis treatment market is poised to undergo a significant transformation.
Read More...
Jun 23, 2023
The GvHD treatment market is anticipated to grow significantly in the coming years as several companies are developing novel therapies.
Read More...
May 05, 2023
Despite many clinically failed attempts, GSK finally set to launch RSVPreF3, the first preventive respiratory syncytial virus vaccine.
Read More...
Apr 26, 2023
Physiotherapy, also called physical therapy, is critical in providing holistic treatment for various disorders, injuries, and diseases. It improves mobility, strength, balance, and coordination. Especially in the case of injury, or chronic pain, it can have a long-lasting impact and greatly help manage the symptoms...
Read More...
Apr 21, 2023
To address challenges, pharma giants GSK & Pfizer are bringing first vaccine for respiratory syncytial virus treatment to adult population.
Read More...
Apr 19, 2023
The Body Contouring Devices market is evolving at an immense pace due to the ongoing trends and developments in the domain. Companies are developing new products
Read More...
Apr 14, 2023
DelveInsight has analyzed some of the key abstracts and top data readouts from the American Association for Cancer Research (AACR) 2023. Several pharma and biotech companies
Read More...
Apr 12, 2023
Polymerase Chain Reaction Market is evolving at an immense pace. Several companies are working in the domain. Major trends and developments
Read More...
Apr 07, 2023
The pipeline is very robust as over 75 leading companies are developing novel therapies for plaque psoriasis treatment.
Read More...
Apr 05, 2023
The Drug Delivery Devices Market is evolving at an immense pace owing to ongoing developments in the domain. Several major companies are developing new devices
Read More...
Intratumoral Cancer Therapy: A Potential Weapon To Fight the Battle Against Cancer
Aug 05, 2026
The Next Wave of Radioligand Therapies: 5 Candidates to Watch
Mar 20, 2026
Newsletter/Whitepaper